TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO July 25, 2003
TCL Archive In Brief: Spitz elected President, ASPO: Karmanos Received $6 Million From Chrysler, Ford May 30, 1997
TCL Archive CCOP Budget Needs Hefty Increase To Fund 55 Awards At Requested Levels, Yates Says January 30, 1987
